Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina

Background: In the last two decades, the use of erythropoietin for the correction of anemia in hemodialysis patients has been recommended. In Chile, only 10% of hemodialysis patients use erythropoietin, therefore, the correction of iron deficiency must be optimized. Aim: To report the effects of int...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alvo A,Miriam, Elgueta S,Leticia, Aragón V,Henry, Cotera F,Alejandro
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2002
Materias:	Anemia, iron-deficiency Erythropoietin Hemodialysis Iron compunds
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000800004
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872002000800004
record_format	dspace
spelling	oai:scielo:S0034-988720020008000042014-08-21Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetinaAlvo A,MiriamElgueta S,LeticiaAragón V,HenryCotera F,Alejandro Anemia, iron-deficiency Erythropoietin Hemodialysis Iron compunds Background: In the last two decades, the use of erythropoietin for the correction of anemia in hemodialysis patients has been recommended. In Chile, only 10% of hemodialysis patients use erythropoietin, therefore, the correction of iron deficiency must be optimized. Aim: To report the effects of intravenous iron without erythropoietin in the management of anemia in hemodialysis patients. Material and methods: Retrospective analysis of 42 patients that received intravenous ferrous sacarate in doses of 100 mg/week during 5 weeks and 100 mg bimonthly during six months. These patients did not receive erythropoietin. Results. Thirty six patients had iron deficiency. Basal ferritin was 137±22 µg/l and increased to 321±28 µg/l after treatment. Packed red cell volume increased from 24±2% to 29±3%. No adverse effects were reported. Conclusions: Iron deficiency is frequent in hemodialyzed patients. Intravenous iron is safe and effective in the treatment of iron deficiency in these patients (Rev Méd Chile 2002; 130: 865-8)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.130 n.8 20022002-08-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000800004es10.4067/S0034-98872002000800004
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Anemia, iron-deficiency Erythropoietin Hemodialysis Iron compunds
spellingShingle	Anemia, iron-deficiency Erythropoietin Hemodialysis Iron compunds Alvo A,Miriam Elgueta S,Leticia Aragón V,Henry Cotera F,Alejandro Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
description	Background: In the last two decades, the use of erythropoietin for the correction of anemia in hemodialysis patients has been recommended. In Chile, only 10% of hemodialysis patients use erythropoietin, therefore, the correction of iron deficiency must be optimized. Aim: To report the effects of intravenous iron without erythropoietin in the management of anemia in hemodialysis patients. Material and methods: Retrospective analysis of 42 patients that received intravenous ferrous sacarate in doses of 100 mg/week during 5 weeks and 100 mg bimonthly during six months. These patients did not receive erythropoietin. Results. Thirty six patients had iron deficiency. Basal ferritin was 137±22 µg/l and increased to 321±28 µg/l after treatment. Packed red cell volume increased from 24±2% to 29±3%. No adverse effects were reported. Conclusions: Iron deficiency is frequent in hemodialyzed patients. Intravenous iron is safe and effective in the treatment of iron deficiency in these patients (Rev Méd Chile 2002; 130: 865-8)
author	Alvo A,Miriam Elgueta S,Leticia Aragón V,Henry Cotera F,Alejandro
author_facet	Alvo A,Miriam Elgueta S,Leticia Aragón V,Henry Cotera F,Alejandro
author_sort	Alvo A,Miriam
title	Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
title_short	Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
title_full	Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
title_fullStr	Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
title_full_unstemmed	Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
title_sort	corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina
publisher	Sociedad Médica de Santiago
publishDate	2002
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872002000800004
work_keys_str_mv	AT alvoamiriam correcciondelaanemiaenhemodialisisefectodelfierrointravenososineritropoyetina AT elguetasleticia correcciondelaanemiaenhemodialisisefectodelfierrointravenososineritropoyetina AT aragonvhenry correcciondelaanemiaenhemodialisisefectodelfierrointravenososineritropoyetina AT coterafalejandro correcciondelaanemiaenhemodialisisefectodelfierrointravenososineritropoyetina
_version_	1718436049417404416

Corrección de la anemia en hemodiálisis, efecto del fierro intravenoso sin eritropoyetina

Ejemplares similares